A critical analysis of financial distress syndrome in selected pharmaceutical companies in India

dc.contributor.guide	Singh, Mohar
dc.coverage.spatial	Business administration
dc.creator.researcher	Chaurasia, Sandeep Kumar
dc.date.accessioned	2021-07-22T03:25:41Z
dc.date.available	2021-07-22T03:25:41Z
dc.date.awarded
dc.date.completed	2018
dc.date.registered
dc.description.abstract	none
dc.description.note	bibliography p.216-226
dc.format.accompanyingmaterial	None
dc.format.dimensions	-
dc.format.extent	226 p.
dc.identifier.uri	http://hdl.handle.net/10603/333055
dc.language	English
dc.publisher.institution	Department of Accountancy and Business Statistics
dc.publisher.place	Rajasthan
dc.publisher.university	University of Rajasthan
dc.relation	-
dc.rights	university
dc.source.inflibnet	INFLIBNET
dc.subject.keyword	Business
dc.subject.keyword	Chemical industry
dc.subject.keyword	Drug packaging industry
dc.subject.keyword	Economics and Business
dc.subject.keyword	Financial distress
dc.subject.keyword	Pharmaceutical industry
dc.subject.keyword	Social Sciences
dc.title	A critical analysis of financial distress syndrome in selected pharmaceutical companies in India
dc.title.alternative	-
dc.type.degree	Ph.D.